HER2 (ERBB2) Mutations in NSCLC: Mechanism of Disease

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

HER2 (ERBB2) Mutations in NSCLC: Mechanism of Disease

Program Information

Program Information

ReachMD Healthcare Image

    Find out how HER2 mutations can lead to the development of NSCLC and other cancers.

    • Sponsored by

    • Overview

      HER2 (ERBB2) mutations may increase receptor internalization and lead to  hyperactive downstream signaling, uncontrolled cell growth, and tumorigenesis. Learn more about how HER2 mutations affect several types of cancer, including non-small cell lung cancer (NSCLC).

      Intended for US Healthcare Professions only 

      ©2022 Daiichi Sankyo, Inc. and AstraZeneca. PP-US-8201a-1332 06/22

    Schedule5 Dec 2022